Granules India Ltd.

NSE: GRANULES | BSE: 532482 | ISIN: INE101D01020 | Industry: Pharmaceuticals
| Mid-range Performer
509.4000 -14.50 (-2.77%)
NSE Jun 13, 2025 15:31 PM
Volume: 1.0M
 

509.40
-2.77%
HDFC Securities
Maintain BUY with a revised TP of Rs 185 (16x June19E EPS). After several quarters of muted top-line growth, GRAN reported 10.2% growth in 1QFY18. Top-line came in at Rs 3.78bn, 5% ahead of estimates. The EBITDA margin at 20.3% was up 40bps YoY, in-line with expectations. While the gross margin expanded ~330bps YoY owing to the improving business mix, higher operating expenses prevented further expansion in the EBITDA margin. PAT was Rs 368mn, down ~5%YoY, largely owing to lower other income (Rs 4mn vs Rs 30mn YoY) and a higher tax rate.
Granules India Ltd. is trading below its 150 day SMA of 531.6
More from Granules India Ltd.
Recommended